CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies

Series paper addresses increased cancer burden in people with HIV, the increasing evidence for safety & efficacy of immunotherapies in context of HIV and cancer, and opportunities for novel applications of CAR-T therapy for treatment of both haematological malignancies & HIV.


The Lancet Haematology